This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Knickole L Bergman: Innovator in Kinase Inhibitors
Introduction
Knickole L Bergman is an inventor based in Jefferson, MD (US). He is known for his work in the field of kinase inhibitors, focusing on developing compounds that can potentially treat diseases characterized by the overexpression of specific kinases. His innovative approach aims to address significant medical challenges through targeted therapies.
Latest Patent Applications
Knickole L Bergman has submitted several notable patent applications. One of his latest applications is for "MIXED LINEAGE KINASE INHIBITORS AND METHODS OF USE." This application discloses compounds that inhibit kinase activity, which may be used to treat diseases associated with the overexpression of mixed lineage kinases (MLKs). The compounds are described to have a specific structure, including stereoisomers, tautomers, or pharmaceutically acceptable salts. Another significant application is for "LZK-TARGETING DEGRADERS AND METHODS OF USE." This application details leucine zipper-bearing kinase (LZK) targeted degraders, which are designed to inhibit LZK activity and potentially degrade LZK. These compounds may also be utilized in treating conditions linked to LZK overexpression.
Conclusion
Knickole L Bergman is an emerging inventor whose work in kinase inhibitors holds promise for advancing therapeutic options in medicine. His latest patent applications reflect a commitment to innovation in the field of biochemistry and pharmacology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile